Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21243972rdf:typepubmed:Citationlld:pubmed
pubmed-article:21243972lifeskim:mentionsumls-concept:C0920317lld:lifeskim
pubmed-article:21243972lifeskim:mentionsumls-concept:C0027092lld:lifeskim
pubmed-article:21243972lifeskim:mentionsumls-concept:C0002475lld:lifeskim
pubmed-article:21243972lifeskim:mentionsumls-concept:C0547070lld:lifeskim
pubmed-article:21243972lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:21243972lifeskim:mentionsumls-concept:C0205148lld:lifeskim
pubmed-article:21243972lifeskim:mentionsumls-concept:C1947976lld:lifeskim
pubmed-article:21243972lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:21243972pubmed:issue7lld:pubmed
pubmed-article:21243972pubmed:dateCreated2011-7-7lld:pubmed
pubmed-article:21243972pubmed:abstractTextTo evaluate the current clinical evidence of safety and efficacy of intraoperative topical application of 0.02% mitomycin C (MMC) used for up to 2 minutes after surface ablation for correction of myopia.lld:pubmed
pubmed-article:21243972pubmed:languageenglld:pubmed
pubmed-article:21243972pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21243972pubmed:citationSubsetIMlld:pubmed
pubmed-article:21243972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21243972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21243972pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21243972pubmed:statusMEDLINElld:pubmed
pubmed-article:21243972pubmed:monthJullld:pubmed
pubmed-article:21243972pubmed:issn1081-597Xlld:pubmed
pubmed-article:21243972pubmed:authorpubmed-author:StojanovicAle...lld:pubmed
pubmed-article:21243972pubmed:authorpubmed-author:WangQin-meiQMlld:pubmed
pubmed-article:21243972pubmed:authorpubmed-author:FengYi-fanYFlld:pubmed
pubmed-article:21243972pubmed:authorpubmed-author:ChenShi-haoSHlld:pubmed
pubmed-article:21243972pubmed:copyrightInfoCopyright 2011, SLACK Incorporated.lld:pubmed
pubmed-article:21243972pubmed:issnTypePrintlld:pubmed
pubmed-article:21243972pubmed:volume27lld:pubmed
pubmed-article:21243972pubmed:ownerNLMlld:pubmed
pubmed-article:21243972pubmed:authorsCompleteYlld:pubmed
pubmed-article:21243972pubmed:pagination530-41lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:meshHeadingpubmed-meshheading:21243972...lld:pubmed
pubmed-article:21243972pubmed:year2011lld:pubmed
pubmed-article:21243972pubmed:articleTitleMeta-analysis of clinical outcomes comparing surface ablation for correction of myopia with and without 0.02% mitomycin C.lld:pubmed
pubmed-article:21243972pubmed:affiliationWenzhou Medical College, Zhejiang, China.lld:pubmed
pubmed-article:21243972pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21243972pubmed:publicationTypeReviewlld:pubmed
pubmed-article:21243972pubmed:publicationTypeMeta-Analysislld:pubmed